Non-human Primate Schlafen11 Inhibits Production of Both Host and Viral Proteins
PLoS Pathogens, ISSN: 1553-7374, Vol: 12, Issue: 12, Page: e1006066
2016
- 37Citations
- 13Usage
- 57Captures
- 6Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations37
- Citation Indexes37
- 37
- CrossRef32
- Usage13
- Downloads12
- Abstract Views1
- Captures57
- Readers57
- 57
- Mentions6
- News Mentions5
- News5
- Blog Mentions1
- Blog1
Most Recent Blog
Genetic Engineering-Based Therapies for Infectious Diseases
By David Warmflash Gene therapy is in a golden age and more and more physicians and laypeople are growing aware of …Continue reading →
Most Recent News
New broad-spectrum antiviral protein can inhibit HIV, other pathogens in some primates
University of Colorado Boulder researchers have discovered that a protein-coding gene called Schlafen11 (SLFN11) may induce a broad-spectrum The post New broad-spectrum antiviral protein can inhibit HIV, other pathogens in some primates has been published on Technology Org.
Article Description
Schlafen11 (encoded by the SLFN11 gene) has been shown to inhibit the accumulation of HIV-1 proteins. We show that the SLFN11 gene is under positive selection in simian primates and is species-specific in its activity against HIV-1. The activity of human Schlafen11 is relatively weak compared to that of some other primate versions of this protein, with the versions encoded by chimpanzee, orangutan, gibbon, and marmoset being particularly potent inhibitors of HIV-1 protein production. Interestingly, we find that Schlafen11 is functional in the absence of infection and reduces protein production from certain non-viral (GFP) and even host (Vinculin and GAPDH) transcripts. This suggests that Schlafen11 may just generally block protein production from non-codon optimized transcripts. Because Schlafen11 is an interferon-stimulated gene with a broad ability to inhibit protein production from many host and viral transcripts, its role may be to create a general antiviral state in the cell. Interestingly, the strong inhibitors such as marmoset Schlafen11 consistently block protein production better than weak primate Schlafen11 proteins, regardless of the virus or host target being analyzed. Further, we show that the residues to which species-specific differences in Schlafen11 potency map are distinct from residues that have been targeted by positive selection. We speculate that the positive selection of SLFN11 could have been driven by a number of different factors, including interaction with one or more viral antagonists that have yet to be identified.
Bibliographic Details
10.1371/journal.ppat.1006066; 10.1371/journal.ppat.1006066.g002; 10.1371/journal.ppat.1006066.g001; 10.1371/journal.ppat.1006066.g003; 10.1371/journal.ppat.1006066.g006; 10.1371/journal.ppat.1006066.g005; 10.1371/journal.ppat.1006066.g004
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85007605052&origin=inward; http://dx.doi.org/10.1371/journal.ppat.1006066; http://www.ncbi.nlm.nih.gov/pubmed/28027315; https://dx.plos.org/10.1371/journal.ppat.1006066.g002; http://dx.doi.org/10.1371/journal.ppat.1006066.g002; https://dx.plos.org/10.1371/journal.ppat.1006066.g001; http://dx.doi.org/10.1371/journal.ppat.1006066.g001; https://dx.plos.org/10.1371/journal.ppat.1006066; https://dx.plos.org/10.1371/journal.ppat.1006066.g003; http://dx.doi.org/10.1371/journal.ppat.1006066.g003; https://dx.plos.org/10.1371/journal.ppat.1006066.g006; http://dx.doi.org/10.1371/journal.ppat.1006066.g006; https://dx.plos.org/10.1371/journal.ppat.1006066.g005; http://dx.doi.org/10.1371/journal.ppat.1006066.g005; https://dx.plos.org/10.1371/journal.ppat.1006066.g004; http://dx.doi.org/10.1371/journal.ppat.1006066.g004; https://scholar.colorado.edu/mcdb_facpapers/14; https://scholar.colorado.edu/cgi/viewcontent.cgi?article=1021&context=mcdb_facpapers; https://dx.doi.org/10.1371/journal.ppat.1006066.g003; https://journals.plos.org/plospathogens/article/figure?id=10.1371/journal.ppat.1006066.g003; https://dx.doi.org/10.1371/journal.ppat.1006066.g004; https://journals.plos.org/plospathogens/article/figure?id=10.1371/journal.ppat.1006066.g004; https://dx.doi.org/10.1371/journal.ppat.1006066.g002; https://journals.plos.org/plospathogens/article/figure?id=10.1371/journal.ppat.1006066.g002; https://dx.doi.org/10.1371/journal.ppat.1006066; https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006066; https://dx.doi.org/10.1371/journal.ppat.1006066.g005; https://journals.plos.org/plospathogens/article/figure?id=10.1371/journal.ppat.1006066.g005; https://dx.doi.org/10.1371/journal.ppat.1006066.g001; https://journals.plos.org/plospathogens/article/figure?id=10.1371/journal.ppat.1006066.g001; https://dx.doi.org/10.1371/journal.ppat.1006066.g006; https://journals.plos.org/plospathogens/article/figure?id=10.1371/journal.ppat.1006066.g006; https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1006066&type=printable; http://dx.plos.org/10.1371/journal.ppat.1006066.g002; http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006066; http://dx.plos.org/10.1371/journal.ppat.1006066.g003; http://www.plosone.org/article/metrics/info:doi/10.1371/journal.ppat.1006066; http://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1006066&type=printable; http://dx.plos.org/10.1371/journal.ppat.1006066.g001; http://dx.plos.org/10.1371/journal.ppat.1006066.g004; http://dx.plos.org/10.1371/journal.ppat.1006066; http://dx.plos.org/10.1371/journal.ppat.1006066.g006; http://dx.plos.org/10.1371/journal.ppat.1006066.g005
Public Library of Science (PLoS)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know